Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 196711

In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin


Clark, C.; Bozdogan, B.; Perić, Mihaela; Dewasse, B.; Jacobs, M.R.; Appelbaum, P.C.
In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin // Antimicrobial agents and chemotherapy, 46 (2002), 9; 2956-2962 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 196711 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin

Autori
Clark, C. ; Bozdogan, B. ; Perić, Mihaela ; Dewasse, B. ; Jacobs, M.R. ; Appelbaum, P.C.

Izvornik
Antimicrobial agents and chemotherapy (0066-4804) 46 (2002), 9; 2956-2962

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
H. influenzae; in vitro mutant selection; amoxicillin-clavulanate; cefpodoxime; cefprozil; azithromycin; clarithromycin

Sažetak
Abilities of amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin to select resistant mutants of Haemophilus influenzae were tested by multistep and single-step methodologies. For multistep studies, 10 random strains were tested: 5 of these were -lactamase positive. After 50 daily subcultures in amoxicillin-clavulanate, MICs did not increase more than fourfold. However, cefprozil MICs increased eightfold for one strain. Clarithromycin and azithromycin gave a >4-fold increase in 8 and 10 strains after 14 to 46 and 20 to 50 days, respectively. Mutants selected by clarithromycin and azithromycin were associated with mutations in 23S rRNA and ribosomal proteins L4 and L22. Three mutants selected by clarithromycin or azithromycin had alterations in ribosomal protein L4, while five had alterations in ribosomal protein L22. Two mutants selected by azithromycin had mutations in the gene encoding 23S rRNA: one at position 2058 and the other at position 2059 (Escherichia coli numbering), with replacement of A by G. One clone selected by clarithromycin became hypersusceptible to macrolides. In single-step studies azithromycin and clarithromycin had the highest mutation rates, while amoxicillin-clavulanate had the lowest. All resistant clones were identical to parents as observed by pulsed-field gel electrophoresis. The MICs of azithromycin for azithromycinresistant clones were 16 to >128 g/ml, and those of clarithromycin for clarithromycin-resistant clones were 32 to >128 g/ml in multistep studies. For strains selected by azithromycin, the MICs of clarithromycin were high and vice versa. After 50 daily subcultures in the presence of drugs, MICs of amoxicillin-clavulanate and cefpodoxime against H. influenzae did not rise more than fourfold, in contrast to cefprozil, azithromycin, and clarithromycin, whose MICs rose to variable degrees.

Izvorni jezik
Engleski

Znanstvena područja
Biologija



POVEZANOST RADA


Ustanove:
Pliva-Istraživački institut

Profili:

Avatar Url Mihaela Perić (autor)


Citiraj ovu publikaciju:

Clark, C.; Bozdogan, B.; Perić, Mihaela; Dewasse, B.; Jacobs, M.R.; Appelbaum, P.C.
In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin // Antimicrobial agents and chemotherapy, 46 (2002), 9; 2956-2962 (međunarodna recenzija, članak, znanstveni)
Clark, C., Bozdogan, B., Perić, M., Dewasse, B., Jacobs, M. & Appelbaum, P. (2002) In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. Antimicrobial agents and chemotherapy, 46 (9), 2956-2962.
@article{article, author = {Clark, C. and Bozdogan, B. and Peri\'{c}, Mihaela and Dewasse, B. and Jacobs, M.R. and Appelbaum, P.C.}, year = {2002}, pages = {2956-2962}, keywords = {H. influenzae, in vitro mutant selection, amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, clarithromycin}, journal = {Antimicrobial agents and chemotherapy}, volume = {46}, number = {9}, issn = {0066-4804}, title = {In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin}, keyword = {H. influenzae, in vitro mutant selection, amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, clarithromycin} }
@article{article, author = {Clark, C. and Bozdogan, B. and Peri\'{c}, Mihaela and Dewasse, B. and Jacobs, M.R. and Appelbaum, P.C.}, year = {2002}, pages = {2956-2962}, keywords = {H. influenzae, in vitro mutant selection, amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, clarithromycin}, journal = {Antimicrobial agents and chemotherapy}, volume = {46}, number = {9}, issn = {0066-4804}, title = {In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin}, keyword = {H. influenzae, in vitro mutant selection, amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, clarithromycin} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font